Literature DB >> 35839088

Tarsal tunnel syndrome: current rationale, indications and results.

E Carlos Rodríguez-Merchán1,2, Immaculada Moracia-Ochagavía1.   

Abstract

Tarsal tunnel syndrome (TTS) is a neuropathy due to compression of the posterior tibial nerve and its branches. It is usually underdiagnosed and its aetiology is very diverse. In 20% of cases it is idiopathic. There is no test that diagnoses it with certainty. The diagnosis is usually made by correlating clinical history, imaging tests, nerve conduction studies (NCSs) and electromyography (EMG). A differential diagnosis should be made with plantar fasciitis, lumbosacral radiculopathy (especially S1 radiculopathy), rheumatologic diseases, metatarsal stress fractures and Morton's neuroma. Conservative management usually gives good results. It includes activity modification, administration of pain relief drugs, physical and rehabilitation medicine, and corticosteroid injections into the tarsal tunnel (to reduce oedema). Abnormally slow nerve conduction through the posterior tibial nerve usually predicts failure of conservative treatment. Indications for surgical treatment are failure of conservative treatment and clear identification of the cause of the entrapment. In these circumstances, the results are usually satisfactory. Surgical success rates vary from 44% to 96%. Surgical treatment involves releasing the flexor retinaculum from its proximal attachment near the medial malleolus down to the sustentaculum tali. Ultrasound-guided tarsal tunnel release is possible. A positive Tinel's sign before surgery is a strong predictor of surgical relief after decompression. Surgical treatment achieves the best results in young patients, those with a clear aetiology, a positive Tinel's sign prior to surgery, a short history of symptoms, an early diagnosis and no previous ankle pathology.
© 2021 The author(s) 2021.

Entities:  

Year:  2021        PMID: 35839088      PMCID: PMC8693231          DOI: 10.1302/2058-5241.6.210031

Source DB:  PubMed          Journal:  EFORT Open Rev        ISSN: 2058-5241


Introduction

Tarsal tunnel syndrome (TTS), first defined in 1962 by Keck[1] and Lam[2], is a compressive peripheral neuropathy of the posterior tibial nerve and its branches within the tarsal tunnel beneath the flexor retinaculum.[3,4] The prevalence of TTS is low relative to other compressive neuropathies, although it is often underdiagnosed and even misdiagnosed as plantar fasciitis.[1,4,5] According to Schon, nerve entrapment, neuropathy, and nerve dysfunction in the legs, ankles, and feet of athletes are not unusual problems.[6] Often, the aforementioned problems are neglected as the more noticeable musculoskeletal lesion draws the orthopaedic surgeon’s attention. Commonly, with conservative management, including a sporadic injection of local anaesthetic with and without corticosteroid, resolution is attained. Hardly ever, symptoms are severe and diffuse enough to need administration of a tricyclic antidepressant medication to diminish the nerve irritability. In cases that fail to respond to conservative management and have well-localized neurologic findings, surgery might be indicated. During the surgical procedure, the nerve should be minimally manipulated. The surrounding veins, arteries, and fat must be relatively undisturbed. Crucial to comprehending and managing these conditions is a thorough knowledge of the peripheral neuroanatomy.[6] The optimal treatment of TTS is still a controversial issue. The controversy is mainly due to its diagnostic difficulties.[7-9] The purpose of this article is to review current knowledge on TTS and its treatment options.

Relevant anatomy of the tarsal tunnel

The flexor retinaculum joins the medial malleolus with the calcaneus to form the roof of the tarsal tunnel, which is an osteofibrous tunnel. Forming part of the wall and floor of this tunnel, covered by their own sheaths, are the tendons of the tibialis posterior, flexor digitorum longus and flexor hallucis longus. The tarsal tunnel is occupied by the posterior tibial artery and veins and the posterior tibial nerve. The posterior tibial nerve, after exiting the peroneal nerve above the popliteal fossa, runs down the back of the leg until it reaches the posteromedial aspect of the ankle. To reach the foot it passes through the tarsal tunnel and can be compressed at that level. The floor of the tarsal tunnel is formed by the talus, the calcaneum and the medial wall of the distal tibia. The flexor retinaculum forms the roof. The tibial nerve branches into the medial plantar and lateral plantar nerves, usually within the tarsal tunnel (Fig. 1).
Fig. 1

The anatomy of the posterior tibial nerve is variable. In this patient we can see the nerve and its main branches: medial plantar nerve, lateral plantar nerve, calcaneal nerve and the first branch of the lateral plantar nerve known as Baxter’s nerve.

The anatomy of the posterior tibial nerve is variable. In this patient we can see the nerve and its main branches: medial plantar nerve, lateral plantar nerve, calcaneal nerve and the first branch of the lateral plantar nerve known as Baxter’s nerve. The lateral branch (lateral plantar nerve) generates a first branch known as the Baxter nerve[10] that innervates the abductor digiti minimi and then passes through the abductor hallucis longus to the lateral surface of the foot. This nerve provides sensory innervation to the medial region of the calcaneus and lateral heel area, and motor function to the flexor digitorum brevis and quadratus plantae.[11] Compression of the Baxter nerve can be the cause of talalgia, which is associated or not with plantar fasciitis. The nerve is usually compressed between the deep fascia of the abductor hallucis muscle and the inferomedial region of the quadratus plantae muscle. These nerves provide sensation to the sole of the foot and control the intrinsic muscles of the foot. Exiting from the posterior tibial nerve is the medial calcaneal nerve, which passes through the flexor retinaculum to provide sensory innervation to the heel. Although there can be anatomical variations, in 25% of cases, the medial calcaneal nerve branches from the lateral plantar nerve.[12-15] Generally the sensory disturbance in TTS affects the heel area because the calcaneal branches form before entering the tarsal tunnel.[16] Singh and Kumar described a dorsal extension of the medial border of the plantar fascia (the deep fascia of the abductor hallucis muscle) as well as the medial septum.[17] Heimkes et al dissected 60 feet, and observed that in almost all feet this medial septum was located between the medial and lateral plantar nerves, was attached to the deep fascia of the abductor hallucis muscle, and originated from the calcaneus or from the sheath of the flexor hallucis longus (Fig. 2).[18] That is, in most cases the medial plantar nerve, lateral plantar nerve, Baxter nerve, and calcaneal branches run through different channels that are divided by osteofibrous structures. This structure explains why there can be isolated compression of each nerve branch in its corresponding osteofibrous tube.
Fig. 2

Deep fascia of the abductor hallucis muscle. It must be sectioned because it is also a frequent cause of isolated compression of some of the terminal branches of the tibial nerve.

Deep fascia of the abductor hallucis muscle. It must be sectioned because it is also a frequent cause of isolated compression of some of the terminal branches of the tibial nerve.

Aetiology

Compression of the posterior tibial nerve and its branches can be extrinsic, as for example in sequelae of ankle fractures and sprains, foot deformities (flat foot, varus or valgus deformity of the foot), overweight and systemic diseases (rheumatoid arthritis, osteoarthritis, hyperlipidaemia, or diabetes) or intrinsic due to space-reducing lesions in the tarsal tunnel (perineural fibrosis, extraneural ganglion cysts, tophaceous tendinitis in the flexor hallucis longus-FHL tendon, osteophytes, hypertrophy of the flexor retinaculum, calcaneal osteochondroma, lipomas or other tumours, tendons or accessory muscles, and vascular anomalies).[19-22] TTS has also been described in cases of tarsal coalition (posterior facet talocalcaneal coalition), medial plantar avulsion fractures of the calcaneus, and even in patients with tight footwear. It has been published that TTS is more frequent in avid runners, especially when hyperpronation of the foot occurs.[23-32] Trauma and related bleeding or posterior adhesions can also cause TTS.[13,30,33] However, in 20% of cases the aetiology of TTS is unclear, i.e. idiopathic.[23-26,34] Table 1 summarizes the main causes of TTS.
Table 1.

Causes of tarsal tunnel syndrome (TTS)

Extrinsic causesIntrinsic causes
Poorly fitted shoesTendinopathy – tenosynovitis
TraumaPerineural fibrosis
Anatomical/biomechanical alterations - Tarsal coalition - Varus/valgus hindfootOsteophytes
Postsurgical scarRetinaculum hypertrophy
Systemic diseases or inflammatory arthropathiesSpace occupying lesions or mass effect - varicose veins - ganglion cyst - lipoma - neoplasia - neuroma
Generalized oedema of lower limbsArterial insufficiency (nervous ischemia)
Diabetes mellitus
Causes of tarsal tunnel syndrome (TTS)

Clinical presentation

Patients with TTS complain of pain in the medial aspect of the ankle, with irradiation to the plantar aspect of the foot. Dysesthesia, paraesthesia, numbness, tingling and burning pain in the sole of the foot are common.[3,13,27] Symptoms usually worsen with weight-bearing activities (prolonged standing or walking) and are relieved when the foot is placed in an elevated position.[13,14] In the physical examination, it is rare to find neurological deficits. In addition, motor weakness of the intrinsic foot muscles is rare and difficult to assess.[22,35] Mild sensory loss can sometimes be detected, although its precise assessment is difficult because of calluses on the sole of the foot.[13] Deep palpation of the medial aspect of the ankle can cause pain.[27,36] In addition, Tinel’s sign is usually present.[20,22,35] There are other manoeuvres that can aid in the diagnosis. The dorsiflexion-eversion test is performed by maximal passive dorsiflexion and eversion of the foot while dorsiflexing the metatarsophalangeal joints.[20,27] In an analysis of 44 feet diagnosed with TTS using electrodiagnostic testing, dorsiflexion-eversion manoeuvring reproduced or aggravated symptoms in 82% of cases, without causing symptoms in normal volunteers.[13] It has also been reported that passive plantarflexion and inversion increase the intracompartmental pressure of the tarsal tunnel.[35] Finally, continuous pressure on the posterior tibial nerve can produce tingling and numbness, the so-called Valleix phenomenon, which is positive in approximately one-third of cases.[20,27] However, the specificity of the aforementioned manoeuvres is low.

Diagnosis

There is currently no test that can reliably diagnose TTS. The diagnosis is usually made by correlating clinical history, imaging tests and nerve conduction studies (NCSs) / electromyography (EMG).[4,2,37,38]

Nerve conduction studies (NCSs) / electromyography (EMG)

NCSs/EMG can be useful for diagnosing TTS, given it can provide objective evidence of nerve compression in the tarsal tunnel or identify an alternative neurological cause (radiculopathy). However, the sensitivity and specificity of NCSs/EMG findings for TTS remain low.[13] The finding most suggestive of TTS is the slowing of nerve conduction velocity through the tarsal tunnel.[39] Plantar nerve NCSs require that their findings be compared with the asymptomatic healthy side. The diagnosis of TTS should not be based solely on alterations detected in the intrinsic foot muscles on EMG, given such alterations can also be observed in asymptomatic individuals.[40] The sensitivity of NCSs of the medial and lateral plantar nerves for the diagnosis of TTS is not sufficiently high. The near nerve method (NNM) is a technique that allows recording large and clear potentials. In medial and lateral plantar nerve NCSs with NNM to diagnose TTS, ultrasound-assisted NNM can be useful because of its simplicity and safety. EMG and nerve conduction studies often produce false negatives.[41-43] EMG is unreliable for confirming the compression of the tibial nerve and its branches.[41]

Imaging

Diagnostic imaging is often useful. Both ultrasound and magnetic resonance imaging (MRI) can be used, although their sensitivity has not been directly compared.[31,44-47] In a study using MRI, a relevant pathology in the tarsal tunnel was identified in 88% of symptomatic cases.[47] MRI could be of diagnostic value in identifying signs compatible with plantar muscular atrophy. In addition, MRI might reveal space-occupying lesions, such as tumours, cysts or varicosities.[4]

Measuring pressure in the tarsal tunnel

Measurement of the pressure in the tarsal tunnel below the flexor retinaculum and medial and lateral plantar tunnels, under the abductor hallucis, could make a reliable diagnosis of TTS.[4] In living patients, Kumar et al [43] measured the pressure in the tarsal tunnel compartment in the neutral position and with plantar and dorsal flexion of the ankle using a water manometer. The values obtained were 4 to 7 mm Hg, 10 to 15 mm Hg and 15 to 20 mm Hg, respectively. Trepman et al measured tarsal tunnel pressures in cadavers, performing measurements in neutral, supination and pronation positions in the ankle and foot.[36] The highest measurement was in pronation, with a mean value of 32 ± 5 mm Hg (2–60 mm Hg). Rosson et al carried out measurements on cadavers in the tarsal tunnel and medial plantar and lateral plantar tunnels for various positions of the ankle and knee, obtaining the highest values with pronation. The values obtained were 1 to 33 mm Hg for the tarsal tunnel, 5 to 50 mm Hg for the medial plantar tunnel and 0 to 56 mm Hg for the lateral plantar tunnel.[48] This study showed that not only the tarsal tunnel (posterior tibial nerve), but also the lateral plantar and medial plantar tunnels (lateral plantar and medial plantar nerves, respectively) need to be decompressed. The reason is that in the plantar tunnels the pressures are very high, even higher than in the tarsal tunnel [48]. Both Rosson et al[48] and Trepman et al[36] used the same device, manufactured by Stryker (Stryker 295 IntraCompartmental Pressure Monitor System, Quick Pressure Monitor Set, Stryker, Kalamazoo, MI).

Differential diagnosis

When a patient presents with foot pain and paraesthesia, we need to consider entities other than TTS that can present similarly.[49] Lumbosacral radiculopathy, especially S1 radiculopathy, can present with patchy sensory symptoms involving the sole of the foot and are commonly unilateral or asymmetric. If the symptoms are bilateral, polyneuropathy should be ruled out. Plantar fasciitis produces pain in the sole of the foot that is usually worse in the morning when the patient takes the first steps out of bed. However, the pain improves during the day. Rheumatologic diseases can themselves produce ankle and foot pain. Although such diseases can increase the risk of TTS, their prevalence alone is higher than that of TTS and, therefore, they are more likely to be the cause of the symptoms. Metatarsal stress fractures can occur from running and other weight-bearing physical activities, although they usually cause localized pain on the dorsum of the foot. Finally, Morton’s neuroma (interdigital neuroma between the third and fourth metatarsals) can also produce pain and paraesthesia, although usually without affecting the entire sole of the foot.[49]

Treatment of tarsal tunnel syndrome (TTS)

It is essential that the treatment of TTS be directed at the cause of the symptoms.[13] However, such treatment remains a challenge because of the diagnostic difficulty and lack of clarity about which patients will benefit from conservative versus surgical treatment. Treatment of TTS can be either surgical or non-surgical. The choice is usually made based on the aetiology of the problem and the degree of loss of function of the foot and ankle, and muscle atrophy.[49-51] Surgical treatment is most useful for treating lesions that occupy space within the tarsal tunnel.[13,31,52] In the absence of an identifiable lesion, the role of surgery is poorly defined; in fact, in these circumstances the results published in the literature are variable.[53,54]

Non-surgical treatment

Conservative management is usually successful. The goal is to relieve pain, inflammation and tissue stress. Abnormally slow nerve conduction through the posterior tibial nerve usually predicts failure of conservative treatment.[49] Conservative management includes activity modification, pain relief drugs, physical and rehabilitation medicine, and corticosteroid injections into the tarsal tunnel (to reduce oedema).[9,14,27,55] Pain-relieving drugs include oral analgesics (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs). Drugs for neuropathic pain (gabapentin, pregabalin, and tricyclic antidepressants) can be used. Topical medications (lidocaine and NSAIDs) can also be used. Physical and rehabilitation medicine modalities for soft tissues that might help include cryotherapy, supportive inserts, changing to better fitting shoes or orthotic shoes, immobilization utilizing splints, ultrasound, iontophoresis, phonophoresis and E-stim. Calf stretching and nerve mobility or nerve gliding can also relieve symptoms. Strengthening the tibialis posterior can also help. Kinesiology tape can be used for arch support and biomechanical stress reduction. Orthopaedic shoes can correct biomechanical abnormalities and unload the tarsal tunnel. A medial heel wedge or heel seat can reduce traction on the nerve by inverting the heel. Night splints and CAM (controlled ankle motion) walkers or temporary walking boots can also be used. Footwear with appropriate arch support can help reduce symptoms. If a ganglion cyst is present, it can be aspirated under ultrasound guidance.[49]

Surgical treatment

According to Kiel and Kaiser, the indications for surgical treatment of TTS are failure of conservative treatment and clear identification of the cause of the entrapment. In these circumstances, the results are usually satisfactory).[49] Surgical treatment involves the release of the flexor retinaculum from its proximal attachment near the medial malleolus down to the sustentaculum tali, and sectioning the deep fascia of the abductor hallucis muscle to eliminate any possible compression of any of the terminal branches of the tibial nerve (Fig. 3). Surgical success rates vary from 44% to 96%. Patients who achieve better results are those with a clear aetiology, a positive Tinel’s sign prior to surgery, a younger age, those with a short history of symptoms, an early diagnosis, and no prior ankle pathology (Fig. 4).[49]
Fig. 3

Surgical approach in tarsal tunnel syndrome (TTS): 5–6 cm incision, 1.5 cm posterior to the tibial malleolus, slightly arched towards the plantar region: (a) marked incision line; (b) surgical incision made.

Fig. 4

(a) Incision and opening of the flexor retinaculum longitudinally and in line with the skin incision. Note inside the posterior tibial nerve and how its branches pass deep to the abductor hallucis muscle; (b) identification of the medial plantar and lateral plantar branches of the tibial nerve.

Surgical approach in tarsal tunnel syndrome (TTS): 5–6 cm incision, 1.5 cm posterior to the tibial malleolus, slightly arched towards the plantar region: (a) marked incision line; (b) surgical incision made. (a) Incision and opening of the flexor retinaculum longitudinally and in line with the skin incision. Note inside the posterior tibial nerve and how its branches pass deep to the abductor hallucis muscle; (b) identification of the medial plantar and lateral plantar branches of the tibial nerve. Still et al evaluated the efficacy of intraoperative neuromonitoring (INM) as an adjunct to surgical tarsal tunnel decompression in 38 patients.[56] INM was used to measure the voltage of the abductor hallucis and digiti quinti muscles before and after decompression. Intraoperative changes were acute and occurred within minutes of surgical decompression. Of the 38 patients studied, 29 (76%) had excellent results, with a mean change in microvolts of 2088.28 ± 1172.44 (684%) (p = 0.0004) and 2173.24 ± 1228.39 (742%) (p = 0.0014) for abductor hallucis and abductor digiti quinti, respectively. Thus, it appears that INM was a useful adjunct to surgical decompression of the tarsal tunnel.[56] Yunoki et al analysed six cases of idiopathic TTS treated by tarsal tunnel opening, neurovascular decompression, and fascial release of the abductor hallucis muscle.[7] In all cases, the preoperative nerve conduction test confirmed delayed sensory conduction velocity. The results were good, although in one case symptoms recurred.[7] Iborra et al have described employing ultrasound-guided tarsal tunnel release for decompression of the tibial nerve, including its distal medial and lateral branches, to treat TTS in 81 patients.[53] Of these, 76.5% had excellent results, 13.5% good results, and 10% poor results. The patients with the longest course of symptoms displayed the poorest results. Ultrasound-guided proximal and distal tarsal tunnel release for TTS provided very satisfactory results, similar to those of conventional and endoscopic techniques, with potentially lower risks, given it does not require exsanguinations of the leg and can be performed under local anaesthesia on an outpatient basis. A possible advantage is that it might decrease the risk of infection, wound complications or fibrosis. Another advantage of ultrasound-guided surgery over open or endoscopic techniques is that it can be performed bilaterally and in combination with other ultrasound-guided techniques, such as gastrocnemius lengthening and partial plantar fasciotomy. For Iborra et al, this technique could be the first surgical option for TTS decompression, given it has been shown to provide satisfactory results. However, these authors also mentioned that the learning curve is long, and that the technique requires a high-resolution ultrasound scanner and training to ensure the reliability of the ultrasound images. Therefore, they considered that further studies were needed to decide the best timing for surgery and to determine whether a surgical variant such as the hallucis abductor septum section could improve outcomes.[53] Postoperative rehabilitation is essential and aims to protect joint and nerve integrity and control inflammation and pain. Contraction and adhesions of scar tissue must be avoided, while maintaining soft tissue and joint mobility. The long-term goal is to achieve normal gait, walking, and running.[49]

Prognosis

The prognosis of tarsal tunnel is variable.[49] When the aetiology of the problem is a mass effect in the tarsal tunnel and it is detected early, the outcome is usually favourable. However, surgical decompression does not usually have a good prognosis in patients in whom no identifiable cause has been detected and who have not responded to conservative treatment. A positive Tinel’s sign before surgery is a strong predictor of surgical relief after decompression.[49] A special situation concerns diabetes. A study of patients with diabetic neuropathy who also had positive Tinel’s sign and an enlarged tibial nerve on ultrasound showed no difference in symptoms or nerve size after surgical decompression of the tarsal tunnel.[57] However, another publication on diabetic sensorimotor polyneuropathy has stated that release of the tarsal tunnel restored sensations in the sole of the foot.[58] Rinkel et al have shown that patients with TTS have an increased risk of diabetic foot ulceration (DFU) due to elevated sensory thresholds. They evaluated the impact of TTS and initial sensory loss on DFU, given tibial nerve decompression could change the natural history of the disease (preventing diabetic foot disease and thus reducing the risk of amputation).[59] It was observed that bilaterally affected patients have a poorer evolution compared to unilateral patients and controls, and they have a higher risk of developing DFU than unilateral patients. Thus, it appears that surgical decompression of the tarsal tunnel in diabetic patients with TTS might decrease the risk of developing DFU.[60-62] Re-innervation of the desensitized foot is expected to be very rapid. This outcome makes this type of surgery a promising therapy to combat the increasingly burdensome and costly DFU pandemic.[63,64] However, surgery for low extremities neuropathic disease (LEND) remains controversial.[65]

Complications

Untreated or refractory TTS can lead to neuropathies of the posterior tibial nerve and its branches, causing patients persistent pain. In addition, motor weakness and atrophy can subsequently develop. Postoperative complications include impaired surgical wound healing, infection and scar formation. Finally, surgical decompression sometimes does not adequately resolve pain and other symptoms.[49] One important complication is the so-called ‘failed tarsal tunnel release’. In 2011, Gould stated that failed surgical releases of the tarsal tunnel might be due to a number of causes. Many of the failures are due to lack of appreciation of the involved anatomy or unsound surgical technique. When a deficient release is performed, a revision simply completes the necessary steps. When external scarring is the problem, barrier materials may be utilized to help protect the nerve after neurolysis. When intrinsic damage is the problem, nerve wrapping surgery technique, reconstruction, conduits, and nerve stimulators all play a role to re-establish function or improve pain.[66] Another significant complication is the recurrence of tarsal tunnel syndrome after surgery. According to Gould, its main causes are deficient release, lack of comprehending or appreciation of the genuine anatomy implicated, variations in the anatomy of the nerve(s), failure to carry out the release accurately, bleeding with consequent scarring, damage to the nerve and branches, continuous hypersensitivity of the nerves, and pre-existing intrinsic damage to the nerve. Strategies include more thorough release, utilization of barrier materials to diminish adherence of the nerve to surrounding tissues to elude traction neuritis, excisions of neuromas utilizing conduits, and consideration of nerve stimulators and systemic medications to deal with continuous neural pain.[67]

Conclusions

Conservative management is usually successful. Abnormally slow nerve conduction through the posterior tibial nerve usually predicts failure of conservative treatment. Conservative management includes activity modification, pain relief drugs (acetaminophen, NSAIDs, drugs for neuropathic pain, topical medications), physical and rehabilitation medicine, and corticosteroid injections into the tarsal tunnel. Physical and rehabilitation medicine modalities include: cryotherapy, supportive inserts (footwear with appropriate arch support, a medial heel wedge or heel seat), changing to better fitting shoes or orthotic shoes, immobilization using splints, ultrasound, iontophoresis, phonophoresis, E-stim, calf stretching and nerve mobility or nerve gliding, strengthening the tibialis posterior, kinesiology tape, night splints and CAM temporary walkers or walking boots. If a ganglion cyst is present, it can be aspirated under ultrasound guidance. Indications for surgical treatment of TTS are failure of conservative treatment and clear identification of the aetiology of the problem. In these circumstances, the results are usually satisfactory, although success rates vary from 44% to 96%. Surgical treatment involves the release of the flexor retinaculum from its proximal attachment near the medial malleolus down to the sustentaculum tali. Patients who achieve better results are those who are younger, have no prior ankle pathology, have an early diagnosis, have a clear aetiology, have a positive Tinel’s sign prior to surgery, and have a short history of symptoms.
  65 in total

1.  Tibial nerve decompression in patients with tarsal tunnel syndrome: pressures in the tarsal, medial plantar, and lateral plantar tunnels.

Authors:  Gedge D Rosson; Allison R Larson; Eric H Williams; A Lee Dellon
Journal:  Plast Reconstr Surg       Date:  2009-10       Impact factor: 4.730

2.  Plantar Medial Avulsion Fracture of the Calcaneus With Acute Tarsal Tunnel: Case Report and Technique Tip [Formula: see text].

Authors:  Kempland C Walley; William L Johns; J Benjamin Jackson; Tyler A Gonzalez
Journal:  Foot Ankle Int       Date:  2020-07-07       Impact factor: 2.827

3.  Evaluation of various fibro-osseous tunnel pressures (carpal, cubital and tarsal) in normal human subjects.

Authors:  K Kumar; S Deshpande; M Jain; M G Nayak
Journal:  Indian J Physiol Pharmacol       Date:  1988 Apr-Jun

4.  The natural history of tarsal tunnel syndrome in diabetic subjects.

Authors:  Willem D Rinkel; Manuel Castro Cabezas; Erwin Birnie; J Henk Coert
Journal:  J Plast Reconstr Aesthet Surg       Date:  2020-02-19       Impact factor: 2.740

5.  Extraneural ganglionic cysts causing tarsal tunnel syndrome.

Authors:  William Huynh; Jeff Kuan; Dennis J Cordato
Journal:  Clin Neurophysiol       Date:  2020-03-29       Impact factor: 3.708

Review 6.  [Tarsal tunnel syndrome. Review of the topic as a result of one case].

Authors:  E López-Gavito; P Parra-Téllez; R Cornejo-Olvera; J Vázquez-Escamilla
Journal:  Acta Ortop Mex       Date:  2014 May-Jun

7.  Tarsal tunnel syndrome caused by ganglia.

Authors:  M Nagaoka; K Satou
Journal:  J Bone Joint Surg Br       Date:  1999-07

8.  Treatment of chronic heel pain by surgical release of the first branch of the lateral plantar nerve.

Authors:  D E Baxter; G B Pfeffer
Journal:  Clin Orthop Relat Res       Date:  1992-06       Impact factor: 4.176

9.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321

10.  Atypical musculoskeletal manifestations on flexor hallucis longus tendon of gout causing tarsal tunnel syndrome in diabetic patients: A case report.

Authors:  Yoon Seok Kim; Min Ki Lee; Young Yi
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.